Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Jan 11

PTSC and TPL are scheduled for a case management conference on Jan 11 in San Jose. The latest documents to be filed are below. Estimated costs??? anyone know what this is for and why it may or may not be significant? With a little luck, perhaps they will settle just in time to announce before the shareholder meeting. If there is any money being held in an escrow account as has been suggested, then perhaps the BoD will announce a dividend again as Ron previously mentioned. Regardless of what may be happening behind the scenes, please do not forget to vote. This is an important election for all shareholders.

0106-000 Cv Ntc:Estimated Costs 12/22/2010 None 12/22/2010
0105-000 Cv Ntc:Prepare Reporter'S Transcript 12/13/2010 None 12/13/2010
Share
New Message
Please login to post a reply